Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Cell Transformation, Neoplastic

etoposide has been researched along with Cell Transformation, Neoplastic in 53 studies

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (16.98)18.2507
2000's25 (47.17)29.6817
2010's17 (32.08)24.3611
2020's2 (3.77)2.80

Authors

AuthorsStudies
Borowsky, AD; Castaneda, A; Dahlem, C; Haarmann-Stemmann, T; He, Y; Ishihara, Y; Jugan, J; Kado, SY; La Merrill, MA; Lazennec, G; Mori, H; Rossi, A; Sweeney, C; Vogel, CFA; Vogeley, C1
Allias Montmayeur, F; Bolze, PA; Descargues, P; Devouassoux-Shisheboran, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; You, B1
Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T1
Deneen, B; Kfoury, N; McDonald, P; Mohila, CA; Qi, Z; Rockwell, N; Roy, A; Rubin, JB; Sun, T; Tinkum, KL; Warrington, NM; Weir, SJ; Yu, K1
Amemiya, K; Hirotsu, Y; Iijima, Y; Kakizaki, Y; Kobayashi, Y; Miyashita, Y; Mochizuki, H; Omata, M; Oyama, T; Tsutsui, T; Uchida, Y1
Gu, Y; Lin, X; Liu, J; Mai, S; Ouyang, M; Qin, Y; Xie, Z; Zhang, J; Zhou, C1
Abbadie, C; Dehennaut, V; Dubuissez, M; Leprince, D; Loison, I; Nassour, J1
Sun, B; Wang, Y; Xu, X; Zhang, L; Zhang, Q; Zhang, Y1
Cui, J; Dong, W; Li, W; Liu, Y; Lu, Y; Xing, R; Yan, Z; Zhang, J; Zhang, X1
Ala, U; Berger, AH; Carver, BS; Castillo-Martin, M; Chen, M; Cordon-Cardo, C; Guarnerio, J; Hobbs, RM; Ishikawa, T; Lunardi, A; Montironi, R; Nardella, C; Ng, C; Pandolfi, PP; Poliseno, L; Quarantotti, V; Seitzer, N; Signoretti, S; Taulli, R; Varmeh, S1
Adachi, J; Fujimaki, T; Fukuoka, K; Matsutani, M; Mishima, K; Nishikawa, R; Shirahata, M; Suzuki, T; Yanagisawa, T1
Hosomi, Y; Koshiji, M; Mo, Y; Rom, WN; Tchou-Wong, KM; Wu, F1
Aqaqe, N; Biechonski, S; Elad, D; Gourevich, D; Grisaru, D; Jaffa, AJ; Milyavsky, M; Olender, L; Rall, M; Raz, Y; Trakhtenbrot, L; Wiesmuller, L; Yassin, M; Zipin-Roitman, A1
Anhalt, GJ; Hosler, GA; Liégeois, N; Moresi, JM1
Damania, B; Wang, L1
Bai, YX; Chen, YC; Feng, F; Huang, CF; Huang, JJ; Huang, PT; Jin, R; Kung, HF; Lin, J; Ma, HH; Peng, Y; Sun, SP; Wang, XX; Wang, ZL; Yang, P; Zhang, B1
Aoyama, M; Asai, K; Kataoka, H; Kubota, E; Tada, T1
Marks, PA; Namdar, M; Ngo, L; Perez, G1
Blanco-Aparicio, C; Cañamero, M; Carnero, A; Cecilia, Y; Ferrer, I; Fominaya, J; Hernandez-Losa, J; Lleonart, M; Peregrina, S; Ramon y Cajal, S1
Balzer, E; Grabias, B; Kontrogianni-Konstantopoulos, A; Mameza, MG; Perry, NA; Shriver, M1
Hamamoto, K; Hasegawa, D; Kikuchi, A; Kojima, S; Manabe, A; Nakahata, T; Ohtsuka, Y; Okamura, J1
Chang, WJ; Chou, HY; Li, TK; Shen, TL; Tai, PH; Yang, YC1
Cary, RB; Garrard, WT; Lanuszewska, J; Widlak, P1
Chang, I; Cho, N; Koh, JY; Lee, MS1
Antonelli, A; Biroccio, A; Elli, R; Gabellini, C; Marcucci, L; Nigro, G; Petrinelli, P; Russo, G; Zupi, G1
Coleman, TA; Dainer, P; Hamill, RL; Redger, CD1
Haslett, C; Jodrell, D; Lucas, CD; MacKinnon, AC; Sethi, T; Tufail-Hanif, U1
Caviglia, JM; Igal, RA; Scaglia, N1
Brünner, N; Christensen, IJ; Hofland, KF; Jensen, PB; Lademann, U; Larsen, L; Rømer, MU1
Barbacid, M; Dubus, P; Hunt, SL; Malumbres, M; Martín, A; Odajima, J; Ortega, S1
Bertrand, R; Bossolasco, M; Mes-Masson, AM; Veillette, F1
Kaufmann, WK1
Chignell, CF; Diwan, BA; He, YY; Huang, JL; Pi, J; Waalkes, MP1
Frater, JL; Gardner, LJ; Grosso, LE; Hurley, MY; Kling, CW; Obadiah, JM; Resh, B1
Ito, E; Kanezaki, R; Narayanan, R; Toki, T; Xu, G1
Brünner, N; Christensen, IJ; Davidsen, ML; Johansen, SK; Lademann, U; Larsen, JK; Offenberg, H; Rømer, MU; Sørensen, NM; Würtz, SØ1
Chang, CH; Chen, KC; Chen, YH; Chu, CC; Diau, GY; Loh, IW1
Choi, YK; Chung, YG; Jeon, HM; Jin, X; Jung, JE; Kim, H; Kim, TK; Lee, JB; Lee, JS; Oh, SY; Park, HJ; Park, JW; Sohn, YW; You, S1
Muraki, J; Nakazono, M1
Fujita, M; Shiku, H1
Connor, TM; Knudson, CM; Korsmeyer, SJ; Lowe, SW; McCurrach, ME1
Chen, G; Shu, J; Stacey, DW1
Bender-Götze, C; Creutzig, U; Körholz, D; Niemeyer, C; Ritter, J; Stollmann-Gibbels, B; Zimmermann, M1
Iigaya, T; Ito, K; Umezawa, A1
Ikeda, K; Ikeda, T; Kawakami, K; Sasaki, K; Takahara, J1
Elliott, MJ; Farnsworth, ML; Lock, RB; Murphy, KM; Ranganathan, V; Stribinskiene, L; Sturges, E1
Chin, M; Harada, K; Imashuku, S; Mugishima, H; Nagata, T; Shichino, H; Suzuki, T; Yamada, A1
Fabisiak, JP; Johnson, CS; Lazo, JS; Vogt, A; Wang, AS; Wipf, P1
Chen, G; Hitomi, M; Stacey, DW1
Lin, FT; Lin, WC; Nevins, JR1
Andresen, S; Bolwell, B; Goormastic, M; Kalaycio, M; Kuczkowski, E; McBee, M; Pohlman, B; Sobecks, R; Wise, K1
Mineta, H; Miura, K; Tsutsui, Y; Yokota, N1
Gawron, A; Jakubowicz-Gil, J; Kandefer-Szerszeń, M; Paduch, R1

Reviews

1 review(s) available for etoposide and Cell Transformation, Neoplastic

ArticleYear
Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
    International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:4

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Prednisone; Proto-Oncogene Proteins c-myc; Radiotherapy; Rituximab; Translocation, Genetic; Treatment Outcome; Vincristine; Whole-Body Irradiation

2013

Other Studies

52 other study(ies) available for etoposide and Cell Transformation, Neoplastic

ArticleYear
Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Animals; Animals, Genetically Modified; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred C57BL; Receptors, Aryl Hydrocarbon; Repressor Proteins; Signal Transduction; Time Factors; Tumor Burden; Tumor Cells, Cultured

2021
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    American journal of obstetrics and gynecology, 2021, Volume: 225, Issue:4

    Topics: Adolescent; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine; Young Adult

2021
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 79

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis

2017
Cooperative p16 and p21 action protects female astrocytes from transformation.
    Acta neuropathologica communications, 2018, 02-20, Volume: 6, Issue:1

    Topics: Animals; Astrocytes; Cell Cycle; Cell Survival; Cell Transformation, Neoplastic; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Embryo, Mammalian; Etoposide; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioblastoma; Karyotyping; Male; Mice; Neurofibromin 1; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyridines; Retinoblastoma Protein; RNA, Messenger; Serum; Sex Characteristics; Transfection; Tumor Cells, Cultured

2018
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
    Clinical lung cancer, 2018, Volume: 19, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Drug Resistance, Neoplasm; Drug Substitution; ErbB Receptors; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Small Cell Lung Carcinoma

2018
Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report.
    Cancer biology & therapy, 2019, Volume: 20, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Treatment Outcome

2019
DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
    The Journal of biological chemistry, 2013, Apr-12, Volume: 288, Issue:15

    Topics: Acetylation; Animals; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Chlorocebus aethiops; COS Cells; DNA Breaks, Double-Stranded; DNA Repair; Etoposide; Fibroblasts; Histone Deacetylases; Humans; Kruppel-Like Transcription Factors; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Mutation; Repressor Proteins; Sirtuin 1; Sumoylation; Trans-Activators

2013
miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells.
    DNA repair, 2013, Volume: 12, Issue:9

    Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Cell Cycle Checkpoints; Cell Proliferation; Cell Transformation, Neoplastic; Etoposide; Gene Expression; HCT116 Cells; Humans; MCF-7 Cells; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; RNA Interference; Stomach Neoplasms; Tumor Burden; Tumor Suppressor Protein p53

2013
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Cancer discovery, 2015, Volume: 5, Issue:5

    Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Checkpoint Kinase 1; Conserved Sequence; Disease Progression; DNA Damage; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genotype; Humans; Male; Mice; Mice, Knockout; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Protein Kinases; Proto-Oncogene Proteins c-ets; PTEN Phosphohydrolase; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Regulator ERG; Tumor Suppressor Protein p53

2015
Malignant transformation of germinoma 14 years after onset: Favorable efficacy of oral etoposide.
    Pediatrics international : official journal of the Japan Pediatric Society, 2015, Volume: 57, Issue:3

    Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Transformation, Neoplastic; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Forecasting; Germinoma; Humans; Magnetic Resonance Imaging; Pituitary Gland, Posterior; Time Factors; Young Adult

2015
Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2015, Volume: 34, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Transcription Factors; Zinc Finger Protein GLI1

2015
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
    International journal of cancer, 2017, 02-15, Volume: 140, Issue:4

    Topics: Adult; Ascorbic Acid; Cell Culture Techniques; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Genistein; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Infant; Leukemia; Maternal-Fetal Exchange; Myeloid-Lymphoid Leukemia Protein; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pregnancy; Quercetin; Signal Transduction; Topoisomerase II Inhibitors

2017
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
    Journal of cutaneous pathology, 2008, Volume: 35, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Cutaneous; Middle Aged; Panniculitis; Prednisone; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; T-Lymphocytes; Vincristine

2008
Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.
    Cancer research, 2008, Jun-15, Volume: 68, Issue:12

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Cell Survival; Cell Transformation, Neoplastic; Culture Media, Serum-Free; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblast Growth Factor 2; Herpesvirus 8, Human; Humans; Multienzyme Complexes; Phosphatidylinositol 3-Kinases; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Sarcoma, Kaposi; Signal Transduction; Staurosporine; Survival Rate; TOR Serine-Threonine Kinases; Umbilical Veins; Vascular Endothelial Growth Factor A; Virus Replication

2008
Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
    Cancer research, 2009, Jan-01, Volume: 69, Issue:1

    Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Damage; Etoposide; Gene Silencing; Humans; Mice; Mice, Inbred BALB C; RNA, Small Interfering; Shelterin Complex; Telomerase; Telomere; Telomere-Binding Proteins; Transfection; Tumor Suppressor Proteins

2009
Resistance to chemotherapeutic agents and promotion of transforming activity mediated by embryonic stem cell-expressed Ras (ERas) signal in neuroblastoma cells.
    International journal of oncology, 2010, Volume: 37, Issue:4

    Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Neuroblastoma; Oncogene Protein p21(ras); Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Transfection; Vinblastine

2010
Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Nov-16, Volume: 107, Issue:46

    Topics: Anilides; Antineoplastic Agents; Caspases; Cell Death; Cell Line, Tumor; Cell Transformation, Neoplastic; Checkpoint Kinase 2; DNA Damage; DNA Replication; Down-Regulation; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; G1 Phase; Gene Expression Regulation, Neoplastic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Neoplasm Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Topoisomerase II Inhibitors; Up-Regulation

2010
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
    Cell cycle (Georgetown, Tex.), 2011, Aug-15, Volume: 10, Issue:16

    Topics: ADP-Ribosylation Factor 1; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Doxorubicin; Etoposide; Hydrogen Peroxide; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Knockout; Microfilament Proteins; Nerve Tissue Proteins; Phosphorylation; Protein Phosphatase 1; Retinoblastoma Protein; Tumor Suppressor Protein p53

2011
Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:7

    Topics: Apoptosis; Base Sequence; Breast; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; DNA Damage; Epithelial Cells; Etoposide; Female; Gene Expression; Guanine Nucleotide Exchange Factors; Humans; Muscle Proteins; Protein Isoforms; Protein Serine-Threonine Kinases; Rho Guanine Nucleotide Exchange Factors; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Skin Neoplasms

2012
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
    British journal of haematology, 2012, Volume: 158, Issue:5

    Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Child; Cytarabine; Etoposide; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Mitoxantrone; Remission Induction; Treatment Outcome

2012
Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.
    Antioxidants & redox signaling, 2013, Apr-01, Volume: 18, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Line; Cell Transformation, Neoplastic; Coculture Techniques; DNA Cleavage; DNA Topoisomerases, Type II; Etoposide; HCT116 Cells; HL-60 Cells; Humans; Inflammation; Mice; Mice, Knockout; Mutagenesis; Nitric Oxide; Nitric Oxide Donors; Pyridines; S-Nitrosoglutathione

2013
Subunit structures and stoichiometries of human DNA fragmentation factor proteins before and after induction of apoptosis.
    The Journal of biological chemistry, 2003, Jul-18, Volume: 278, Issue:29

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspases; Cell Line; Cell Transformation, Neoplastic; Dimerization; DNA Fragmentation; Enzyme Activation; Etoposide; HL-60 Cells; Humans; Molecular Weight; Protein Structure, Quaternary; Protein Subunits; Proteins; Recombinant Proteins

2003
Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes.
    Diabetologia, 2003, Volume: 46, Issue:9

    Topics: Adenosine Triphosphate; Animals; Antigens, Polyomavirus Transforming; Antioxidants; Cell Death; Cell Line, Tumor; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Etoposide; Insulinoma; Interferon-gamma; Islets of Langerhans; NAD; Necrosis; Pancreatic Neoplasms; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Staurosporine; Tumor Necrosis Factor-alpha; Zinc

2003
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.
    British journal of cancer, 2003, Sep-15, Volume: 89, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia; Cell Cycle; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 14; Clone Cells; DNA-Binding Proteins; Etoposide; Gene Expression Regulation; Humans; Preleukemia; Proto-Oncogene Proteins; T-Lymphocytes; Telomerase; Telomere; Transcription Factors; Translocation, Genetic

2003
Rectal adenocarcinoma with germ-cell differentiation: report of a case.
    Diseases of the colon and rectum, 2003, Volume: 46, Issue:12

    Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; Germinoma; Humans; Liver Neoplasms; Male; Palliative Care; Rectal Neoplasms

2003
Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.
    British journal of cancer, 2005, Feb-14, Volume: 92, Issue:3

    Topics: Animals; Arginine Vasopressin; Cell Division; Cell Transformation, Neoplastic; Cricetinae; Cricetulus; Etoposide; Gastrin-Releasing Peptide; Humans; Peptide Fragments; Receptors, Neuropeptide; Substance P; Transfection; Tumor Cells, Cultured

2005
High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts.
    Biochimica et biophysica acta, 2005, Feb-21, Volume: 1687, Issue:1-3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Transformed; Cell Transformation, Neoplastic; Etoposide; Fatty Acids, Monounsaturated; Fibroblasts; Humans; Membrane Lipids; PPAR gamma; Simian virus 40; Stearoyl-CoA Desaturase

2005
Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Fibrosarcoma; Lung Neoplasms; Male; Mice; Plasminogen Activator Inhibitor 1

2005
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Cancer cell, 2005, Volume: 7, Issue:6

    Topics: Animals; Body Weight; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Embryo, Mammalian; Etoposide; Fibroblasts; Gene Expression; Hyperplasia; Mice; Mice, Knockout; Mice, Nude; Mutation; Pituitary Neoplasms; Retinal Dysplasia; Retroviridae; Transfection; Tumor Suppressor Proteins

2005
Human TDE1, a TDE1/TMS family member, inhibits apoptosis in vitro and stimulates in vivo tumorigenesis.
    Oncogene, 2006, Aug-03, Volume: 25, Issue:33

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Membrane; Cell Transformation, Neoplastic; Etoposide; Humans; In Vitro Techniques; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Plasmids; Rats; Receptors, Cell Surface; Transfection

2006
Dangerous entanglements.
    Trends in molecular medicine, 2006, Volume: 12, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Transformation, Neoplastic; Chromosome Aberrations; Diketopiperazines; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; G2 Phase; Genomic Instability; Humans; Piperazines; Regenerative Medicine; Stem Cell Transplantation; Stem Cells; Topoisomerase II Inhibitors

2006
Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance.
    Oncogene, 2006, Jun-22, Volume: 25, Issue:26

    Topics: Animals; Apoptosis; Arsenites; Carcinogenicity Tests; Cell Transformation, Neoplastic; Cells, Cultured; Doxorubicin; Etoposide; Humans; Keratin-13; Keratinocytes; Keratins; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Staurosporine; Ultraviolet Rays

2006
Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?
    Journal of cutaneous pathology, 2006, Volume: 33, Issue:6

    Topics: Antigens, CD1; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cell Proliferation; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Histiocytes; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Sarcoma; Skin Neoplasms; Tonsillar Neoplasms; Vincristine

2006
Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:3

    Topics: Animals; Base Sequence; Cell Line, Tumor; Cell Transformation, Neoplastic; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Gene Expression Profiling; Genes, p53; Humans; Leukemia, Megakaryoblastic, Acute; Mice; Molecular Sequence Data; Mutant Chimeric Proteins; NIH 3T3 Cells; RNA-Binding Proteins; Topoisomerase II Inhibitors

2006
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.
    British journal of cancer, 2006, Oct-23, Volume: 95, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; DNA Fragmentation; Dose-Response Relationship, Drug; Etoposide; Female; Gene Expression; Genotype; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Transgenic; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Vincristine

2006
Malignant transformation of a well-organized sacrococcygeal fetiform teratoma in a newborn male.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2007, Volume: 106, Issue:5

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fetus; Humans; Infant, Newborn; Male; Neoplasms, Germ Cell and Embryonal; Pregnancy; Reoperation; Sacrococcygeal Region; Teratoma; Treatment Outcome

2007
Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damage.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:8

    Topics: Animals; Antineoplastic Agents; Astrocytes; Brain Neoplasms; Cell Death; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; Dose-Response Relationship, Drug; Etoposide; Mice; Mice, Nude; Oncogene Protein v-akt; Pepstatins; Reactive Oxygen Species; Time Factors; Transduction, Genetic; Tumor Suppressor Protein p53

2007
[A case of teratoma of the testis with retroperitoneal lymph nodes involved with malignant teratoma after chemotherapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1993, Volume: 84, Issue:12

    Topics: Adenocarcinoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Teratoma; Testicular Neoplasms

1993
Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes.
    Oncogene, 1995, Jul-06, Volume: 11, Issue:1

    Topics: Animals; Apoptosis; Cell Nucleus; Cell Transformation, Neoplastic; Cell Transformation, Viral; Culture Media, Serum-Free; Etoposide; Fibroblasts; Genes, fos; Genes, myc; Genes, p53; Genes, pX; Human T-lymphotropic virus 1; Rats

1995
bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Mar-18, Volume: 94, Issue:6

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Cisplatin; Crosses, Genetic; Doxorubicin; Drug Resistance; Embryo, Mammalian; Etoposide; Fibroblasts; Genes, p53; Mice; Mice, Knockout; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombination, Genetic; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Protein p53

1997
Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide.
    Oncogene, 1997, Oct-02, Volume: 15, Issue:14

    Topics: 3T3 Cells; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Etoposide; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; S Phase; Topoisomerase II Inhibitors

1997
The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.
    Leukemia, 1998, Volume: 12, Issue:5

    Topics: Adolescent; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mitoxantrone; Remission Induction

1998
[Case of testicular cancer with malignant transformation in the residual retroperitoneal mature teratoma 8 years after the initial chemotherapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1998, Volume: 89, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm, Residual; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Vinblastine

1998
The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.
    International journal of hematology, 1999, Volume: 69, Issue:3

    Topics: Cell Transformation, Neoplastic; Chromosomes, Human, Pair 11; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription, Genetic; Translocation, Genetic

1999
Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Nucleus; Cell Transformation, Neoplastic; Etoposide; Genes, bcl-2; HeLa Cells; Humans; Mitosis; Proto-Oncogene Proteins c-bcl-2

1999
Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis: is it secondary leukemia?
    International journal of hematology, 1999, Volume: 70, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Transformation, Neoplastic; Child, Preschool; Dexamethasone; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1999
In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

    Topics: Aminobutyrates; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Cycle Proteins; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Etoposide; Inhibitory Concentration 50; Insulin-Like Growth Factor I; Interleukin-3; Mice; Oxazoles; Receptor, IGF Type 1; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000
Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity.
    Molecular and cellular biology, 2000, Volume: 20, Issue:24

    Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Transformation, Neoplastic; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Fluorescence; Humans; Isoenzymes; Mice; Microinjections; Microscopy, Video; Nucleic Acid Synthesis Inhibitors; Oncogene Protein p21(ras); Oncogenes; Signal Transduction; Topoisomerase II Inhibitors; Video Recording

2000
Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.
    Genes & development, 2001, Jul-15, Volume: 15, Issue:14

    Topics: Amino Acid Sequence; Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Transformation, Neoplastic; Cisplatin; DNA Damage; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Gene Expression Regulation; Humans; Mice; Mice, Mutant Strains; Molecular Sequence Data; Phosphorylation; Protein Serine-Threonine Kinases; Thymus Gland; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2001
Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.
    Clinical lymphoma, 2000, Volume: 1, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Transformation, Neoplastic; Cyclophosphamide; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome

2000
Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy.
    Pathology international, 2001, Volume: 51, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Combined Modality Therapy; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Ganglioneuroma; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Radiotherapy, Adjuvant

2001
The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells.
    Folia histochemica et cytobiologica, 2002, Volume: 40, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Culture Techniques; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Eukaryotic Cells; Fibroblasts; Heat-Shock Proteins; HeLa Cells; Hot Temperature; HSP27 Heat-Shock Proteins; Humans; Models, Biological; Molecular Chaperones; Neoplasm Proteins; Neoplasms; Quercetin; Stress, Physiological

2002